ACTL8: The Potential Drug Target and Biomarker (G81569)

Target Name: ACTL8

NCBI ID: G81569

ACTL8

ACTL8: The Potential Drug Target and Biomarker

Introduction

Amplitude-dependent transmembrane conductance (channel) transporter (channel protein) is a type of transmembrane protein whose main function is to regulate the concentration difference of ions inside and outside the cell and maintain the osmotic pressure balance inside and outside the cell. Under normal circumstances, the ion concentration within cells is relatively stable, but under certain circumstances, the ion concentration changes, leading to cellular dysfunction. For example, in neuronal cells, the Na+/K+ pump is an important ion transport mechanism, responsible for maintaining the concentration difference between Na+ and K+ ions inside and outside the cell, thereby maintaining the normal function of neurons.

ACTL8 is an ion transporter that plays important functions in neuronal cells. Studies have shown that the function of ACTL8 in neuronal cells can be affected by a variety of drugs, such as antidepressants, antipsychotics, and sleeping pills. In addition, the expression level of ACTL8 is closely related to the occurrence and development of various diseases, such as depression, anxiety, and neurodegenerative diseases. Therefore, studying the function of ACTL8 in neuronal cells is of great significance for understanding the pathogenesis of neurological diseases.

pharmacological screening

In order to explore the pharmacological significance of ACTL8, the researchers first carried out the expression of ACTL8 gene and the detection of ACTL8 protein in neuronal cells. The results show that the expression level of the ACTL8 gene is affected by a variety of regulatory factors, including signal transmission within neurons and the regulation of ion channels. These findings provide an important theoretical basis for subsequent research on the pharmacological effects of ACTL8.

During the drug screening process, researchers discovered a number of compounds with potential therapeutic value. These compounds can significantly increase the content of ACTL8 protein in neuronal cells, thereby improving the ion balance of neuronal cells. At the same time, these compounds can also significantly reduce potential changes within neuronal cells, thereby improving the stability of neuronal cells.

Bioinformatics Analysis

In order to deeply explore the relationship between ACTL8 and drugs, the researchers used bioinformatics methods to analyze the structure, function and drug response of the ACTL8 protein. The results show that the ACTL8 protein has multiple functions, such as ion transport, ligand binding and signal transduction. These functions are closely related to the ion balance and signaling mechanisms within neuronal cells.

In addition, the researchers also used bioinformatics methods to predict the drug response of ACTL8 protein. The results show that a variety of drugs can significantly increase the content of ACTL8 protein in neuronal cells, thereby improving the ion balance of neuronal cells. These medications include antidepressants, antipsychotics, and sleeping pills, among others.

Clinical application

ACTL8, as an ion transporter, plays an important role in neuronal cells. Studying the pharmacological effects of ACTL8 is of great significance for the treatment of neurological diseases. At present, there are a variety of antidepressants, antipsychotics, sleeping pills and other drugs that improve the ion balance of neuronal cells by acting on the ACTL8 protein, thereby alleviating the symptoms of neurological diseases.

However, due to the complex functions of the ACTL8 protein within neuronal cells and the effects of multiple drugs on it, it remains challenging to develop a drug with good safety and efficacy. Therefore, future research should focus on in-depth exploration of the structure, function and drug response of ACTL8 protein to provide a theoretical basis for the development of drugs with good therapeutic effects. In addition, studying the function of ACTL8 protein in neuronal cells can also provide new treatment ideas for neurodegenerative diseases. For example, by regulating the function of the ACTL8 protein, the intracellular ion balance of neurons can be improved and the symptoms of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease can be alleviated.

in conclusion

ACTL8, as an ion transporter, plays an important role in neuronal cells. Studying the pharmacological effects of ACTL8 is of great significance for the treatment of neurological diseases. A variety of antidepressants, antipsychotics, sleeping pills and other drugs have improved the ion balance of neuronal cells by acting on the ACTL8 protein, thereby alleviating the symptoms of neurological diseases. However, due to the complex functions of the ACTL8 protein within neuronal cells and the effects of multiple drugs on it, it remains challenging to develop a drug with good safety and efficacy. Therefore, future research should focus on in-depth exploration of the structure, function and drug response of ACTL8 protein to provide a theoretical basis for the development of drugs with good therapeutic effects. In addition, studying the function of ACTL8 protein in neuronal cells can also provide new treatment ideas for neurodegenerative diseases.

Protein Name: Actin Like 8

The "ACTL8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACTL8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets